Business Description
Neovacs SA
ISIN : FR0014018EV4
Compare
Compare
Traded in other countries / regions
ALNEV.France0LW1.Germany0W8U.UK IPO Date
2011-05-24Description
Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 18.36 | |||||
9-Day RSI | 27.4 | |||||
14-Day RSI | 32.64 | |||||
3-1 Month Momentum % | -50 | |||||
6-1 Month Momentum % | -95.56 | |||||
12-1 Month Momentum % | -99.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -1005.46 | |||||
OCF Margin % | -983.88 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neovacs SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.366 | ||
| EPS (TTM) (€) | -33229.438 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.65 | ||
| 3-Year Sortino Ratio | 943.15 | ||
| Volatility % | 71.1 | ||
| 14-Day RSI | 32.64 | ||
| 14-Day ATR (€) | 0.447546 | ||
| 20-Day SMA (€) | 1.37537 | ||
| 12-1 Month Momentum % | -99.99 | ||
| 52-Week Range (€) | 0.892 - 18998 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neovacs SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neovacs SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.0001:1 Stock Split | 2026-06-23 | 2.00 (+0.00%) | ||
| 0.001:1 Stock Split | 2025-07-18 | 18,000.00 (-10.00%) | ||
| 0.0001:1 Stock Split | 2024-12-05 | 3,000.00 (+0.00%) | ||
| 0.0001:1 Stock Split | 2024-02-05 | 20,000.00 (+0.00%) | ||
| 0.000125:1 Stock Split | 2023-06-02 | 8,000.00 (+0.00%) | ||
| 0.0001:1 Stock Split | 2022-02-01 | 24,000.00 (-25.00%) |
Show
Entries
Neovacs SA Frequently Asked Questions
What is Neovacs SA(XPAR:ALNEV)'s stock price today?
The current price of XPAR:ALNEV is €0.90. The 52 week high of XPAR:ALNEV is €18998.00 and 52 week low is €0.89.
When is next earnings date of Neovacs SA(XPAR:ALNEV)?
The next earnings date of Neovacs SA(XPAR:ALNEV) is .
Does Neovacs SA(XPAR:ALNEV) pay dividends? If so, how much?
Neovacs SA(XPAR:ALNEV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Neovacs SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers